Press release
Hemostasis Market Analysis, Segments and Value Chain Till 2020
Hemostasis Analyzers
Table-top devices
Portable devices
Hemostasis Products and Devices
Compression devices
Vascular closure devices
Hemostasis bandages
Hemostasis glues and tissue sealing agents
Gelatin Sponge
Hemostasis Drugs
Tranexamic acid
Etamsylate
Antifibrinolytics
Free Sample Report@ http://www.sa-brc.com/Global-Hemostasis-Market-Assessment--Forecast-2017-2021/up67
With the help of nanotechnology, scientists have successfully developed handheld hemostasis analyzer devices. Application of coagulometer or hemostasis analyzers is increasing in point-of-care setting. This has been a key driver of the hemostasis analyzer segment. Hemostasis tests are used to gauge effective dose of warfarin as excess or insufficient dose may lead to serious complications. These tests are also routinely used in diagnosis of blood related disorders such as hemophilia.
The market is driven by variety of innovative products and devices currently in the market, and others expected to launch in near future. In 2013, Baxter launched collagen based Hemopatch in Europe. The company claims that the hemostatic device is ideal for application in surgical procedures when compression, ligature, or other conventional alternatives of hemostasis are ineffective. Z-Medica also launched a product line of hemostatic agents for application in emergency medical services (EMS). The newly launched products include line includes QuikClot EMS 4x4 Dressing, QuikClot EMS TraumaPad, and QuikClot EMS Rolled Gauze.
ControlClose and CombiClose devices marketed by Morris Innovative are effective in healing femoral artery by using a biologic material called SIS (small intestinal submucosa). These devices can efficiently close arteries as small as 3mm. Another innovative product by Forge Medical called VasoStat is a compression device is one-size-fit-all. The patented device provides focused compression to the radial artery without complete occlusion. Advances in hemostasis devices has helped in reducing casualties in military where maximum mortalities happen due to severe blood loss. Surgeons may choose the best device or a combination depending on the injury type. As an example, for radial artery, wristband type compression device can be ideal, however vascular closure device may not be effective. Wound dressing coated with hemostatic agents can be used in combination with others to accelerate blood clotting process.
Click For Request TOC@ http://www.sa-brc.com/Global-Hemostasis-Market-Assessment--Forecast-2017-2021/upcomingdetail67
The global hemostasis market has witnessed great numbers of strategic agreements in the recent past. In 2012, Johnson&Johnson acquired Guangzhou Bioseal Biotech Co., Ltd. a privately held Chinese company manufacturing porcine-derived fibrin sealant, BIOSEAL. Later in 2013, Merit Medical Systems announced the acquisition of Safeguard Pressure Assisted Device and Air-Band Radial Compression Device from Datascope Corporation. Mallinckrodt plc also entered into an agreement with The Medicine Company to acquire three hemostasis brands Recothram Thrombin, PreveLeak and Raplixa.
About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.
Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hemostasis Market Analysis, Segments and Value Chain Till 2020 here
News-ID: 420470 • Views: …
More Releases from SA-BRC
Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has…
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage.
Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine…
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target…
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients.
The…
More Releases for Hemostasis
Hemostasis Diagnostics Market Forecast Overview, 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Hemostasis Diagnostic Devices And Equipment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $9.85 billion…
Hemostasis Valves Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Hemostasis Valves Market Size Projected to Reach USD 255 Billion by 2030, Growing at 5.80% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Hemostasis Valves Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Hemostasis Diagnostics Market: Global Industry Analysis 2024
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has…
Hemostasis Diagnostics Market: Global Markets & Advanced Technologies
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has…
Hemostasis Products Market: Applications and Global Markets
This report on the global hemostasis products market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study…
Predictions for 2024: Hemostasis Products Market
The top four vendors operating in the global hemostasis products market, including Ethicon, Pfizer Inc., Baxter International, Inc., and CR Bard, Inc., accounted for a share of nearly 41% in the market in 2015, states Transparency Market Research in a recent report. In the seemingly fragmented market, where small- and medium-scale vendors accounted for over 59% in the overall market in the 2015, a large number of these players provided…
